Key Dates

Related Announcements

PAR-22-187 - NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

NOT-CA-22-119 - Notice of Correction to PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Application Types allowed for PAR-22-187, NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed).

The following section of PAR-22-187 has been corrected:

Part 1. Overview Information, Section II. Award Information

Currently reads:

Application Types Allowed

New
Renewal

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.

Corrected to read (in bold italics):

Application Types Allowed

New
Resubmission
Renewal

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.

All other aspects of PAR-22-187 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Christine Siemon
National Cancer Institute (NCI)
Telephone: 240-276-6266
Email: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]